Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Additives colorectal cancer

Colorectal cancer represents the third most commonly diagnosed cancer and is the second leading cause of cancer deaths in the United States (Gazelle et al. 2000). In addition, colorectal cancer is responsible for about 11% of all new cancer cases per year... [Pg.257]

Colorectal Cancer. Colorectal cancer occurs frequently in the UK population but is historically rare in Asia. Rates in Japan have, however, increased rapidly in recent years.Interestingly, there appears to be an association between oestrogen exposure and colon cancer risk has been shown to increase in women with increasing age of first live birth, and to decrease with increasing parity (number of children). In addition, many colon tumours express sex hormone receptors, and this is thought to play a part in development of the tumours. "... [Pg.126]

Additional genes and protein receptors are believed to be important in colorectal tumorigenesis. Cyclooxygenase 2 (COX-2), which is induced in colorectal cancer cells, influences apoptosis and other cellular functions in colon cells, and overexpression of the epidermal growth factor receptor (EGFR), a transmembrane glycoprotein involved... [Pg.1342]

The risk of colon cancer appears to be inversely related to calcium and folate intake. Calciums protective effect may be related to a reduction in mucosal cell proliferation rates or through its binding to bile salts in the intestine, whereas dietary folate helps in maintaining normal bowel mucosa. Additional micronutrient deficiencies have been demonstrated through several studies to increase colorectal cancer risk and include selenium, vitamin C, vitamin D, vitamin E, and 3-carotene however, the benefit of dietary supplementation does not appear to be substantial.11... [Pg.1343]

In view of the reported growing importance ascribed to folic acid deficiency in the prevention of various disease conditions, such as neural tube defects, megaloblastic anemia, colon cancer, and colorectal cancer, a dissolution requirement is specified for folic acid when it is present in multivitamin-mineral combination products. Currently, the dissolution standard required in the official articles of dietary supplements (including vitamin-mineral combination products) places folic acid outside the index vitamin hierarchy. Therefore, a mandatory dissolution test for folic acid is required that is independent of and in addition to the mandatory index vitamin test for multivitamin preparations containing folic acid. [Pg.413]

Cetuximab (Erbitux) is a monoclonal antibody against the epidermal growth factor receptor, EGFR. It is approved for treatment of colorectal cancer. The development of Erbitux was much in the news in 2004 as a result of insider stock trading at ImClone in the face of an initial turndown by the FDA. The former head of ImClone, Sam Waksal, is spending a term of 7 years in jail for his role in the affair. Martha Stewart completed a jail term of several months in the same case. Erbitux was subsequently approved by the FDA on the basis of additional clinical information. [Pg.349]

In addition, very recent work indicates that COX-2 may play a vital role in the regulation of angiogenesis associated with neoplastic tumor cells, hence COX-2 inhibitors may block the growth of blood vessels into developing tumors (56). Thus, according to epidemiological, clinical, and experimental data, COX-2 appears to be intimately related to the development and growth of some types of cancer, especially of colorectal cancer. [Pg.395]

In addition to the usual intravenous or oral routes, some anticancer agents have been administered by regional intraarterial perfusion to increase drug delivery to the tumor itself and at the same time diminish systemic toxicity. Thus, patients with metastatic carcinomas of the liver and little or no disease elsewhere (a common occurrence in colorectal cancer) can be treated with a continuous infusion of fluorouracil or floxuridine through a catheter implanted in the hepatic artery. [Pg.634]

Initial detection of primary colorectal cancer is a domain of endoscopy. Additional imaging for therapy planning is discussed controversially, especially due to the lack of a single comprehensive imaging method [8]. Conventional imaging modalities, comprising endoluminal ultrasound, CT and MRI are limited to give... [Pg.145]


See other pages where Additives colorectal cancer is mentioned: [Pg.86]    [Pg.604]    [Pg.744]    [Pg.1259]    [Pg.363]    [Pg.1321]    [Pg.1343]    [Pg.1344]    [Pg.1348]    [Pg.1348]    [Pg.1348]    [Pg.1349]    [Pg.1351]    [Pg.1353]    [Pg.1354]    [Pg.525]    [Pg.534]    [Pg.77]    [Pg.236]    [Pg.83]    [Pg.320]    [Pg.331]    [Pg.5]    [Pg.66]    [Pg.122]    [Pg.186]    [Pg.343]    [Pg.348]    [Pg.367]    [Pg.351]    [Pg.205]    [Pg.93]    [Pg.399]    [Pg.428]    [Pg.321]    [Pg.323]    [Pg.126]    [Pg.179]    [Pg.717]    [Pg.146]    [Pg.150]    [Pg.153]   
See also in sourсe #XX -- [ Pg.140 , Pg.141 ]




SEARCH



Colorectal cancer

© 2024 chempedia.info